(Q24234510)

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

Combined therapy with low-potency neuroleptic levomepromazine as an adjunct to haloperidol for agitated patients with acute exacerbation of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

Switching female schizophrenic patients to quetiapine from conventional antipsychotic drugs: effects on hyperprolactinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

The use of methyldopa in schizophrenia: a review and comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

Association of the dopamine receptor interacting protein gene, NEF3, with early response to antipsychotic medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

Correlation of Subjective Side Effects with Plasma Concentrations of Nortriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

Statistics notes. Trials randomised in clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

A meta-analysis of the efficacy of second-generation antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

The unit of analysis error in studies about physicians' patient care behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

Issues in the meta-analysis of cluster randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

Levomepromazine receptor binding profile in human brain--implications for treatment-resistant schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

Pharmacokinetics of methotrimeprazine after single and multiple doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

7 January 2021

Metabolism of levomepromazine in man

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

7 January 2021

Ethnic Minority Psychiatric Illness Rates in the Community (EMPIRIC): Quantitative Report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

1 reference

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

7 January 2021

Plasma and erythrocyte levels of methotrimeprazine and two of its nonpolar metabolites in psychiatric patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

7 January 2021

Increased plasma concentrations of bromperidol and its reduced metabolite with levomepromazine, but not with thioridazine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

7 January 2021

Levomepromazine elimination in patients during active and sham hemodialysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

7 January 2021

Assessing a new phenothiazine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

7 January 2021

A comparative controlled trial of methortrimeprazine ("veractil") in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

7 January 2021

A clinical trial of four tranquillizing drugs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

7 January 2021

A clinical trial of largactil (chlorpromazine), stemetil (prochlorperazine) and veractil (methotrimeprazine)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007779.PUB2

7 January 2021